August 06, 2026
Biopharmaceutical Excipients Market (By Product Type: Organic Chemical, Inorganic Chemicals; By Functionality: Stabilizers, Solubilizers & Surfactants, Preservatives, Buffers, Bulking Agents, Others; By Formulation: Oral Formulations, Parenteral ...
April 21, 2026
According to market projections, the biopharmaceutical third-Party logistics sector is expected to grow from USD 143.44 billion in 2024 to USD 276.24 billion by 2034, reflecting a CAGR of 6.62%. The market is growing due to rising global demand...
April 21, 2026
Market insights predict the global biopharmaceutical CDMO industry will increase from USD 20.55 billion in 2024 to USD 46.98 billion by 2034, achieving a CAGR of 8.73%. The biopharmaceutical CDMO market is expanding due to growth in research and deve...
April 21, 2026
According to market projections, the global biopharmaceutical contract manufacturing market, valued at USD 40.14 billion in 2024, is anticipated to reach USD 115.65 billion by 2034, growing at a CAGR of 11.14% over the next decade.The biopharmaceut...
July 24, 2026
The biopharmaceuticals market size is calculated at USD 533.57 bn in 2026 is to hit USD 1540.14 bn by 2035. The biopharmaceuticals market is growing rapidly, driven by advances in biologics, personalized medicine, and gene therapy. Innovations in mon...
April 21, 2026
The biopharmaceuticals CRO market is expanding due to increasing diseases as well as rising clinical trials. North America led the market due to the presence of well-developed biopharmaceutical industries....
April 21, 2026
Based on market forecasts, the plasmid purification sector will expand from USD 1.95 billion in 2024 to USD 5.88 billion by 2034, experiencing a CAGR of 11.64%. In 2024, North America led the plasmid purification market with a 41% share, while Asia P...
April 21, 2026
The advanced therapies in biopharmaceutical medicine market is expanding due to increasing diseases as well as growing gene editing therapies. North America led the market due to the presence of a well-developed healthcare sector....
August 26, 2026
Market insights predict, the U.S. biopharmaceutical third-party logistics industry is expected to grow from USD 61.08 billion in 2025 to USD 127.06 billion by 2035, driven by a CAGR of 7.6%. Rising complexities and volume of biopharmaceutical product...
August 18, 2026
Payal Rabde is a Healthcare Market Research Analyst specializing in the biopharmaceutical process analytical technology market. She tracks the growing demand for single-use bioprocessing systems, quality control solutions, and biologics. Her rese...
April 21, 2026
According to forecasts, the global AI in biopharmaceuticals market will grow from USD 1.55 billion in 2024 to USD 24.49 billion by 2034, with an expected CAGR of 32.27%. The implementation of artificial intelligence in biotechnology and pharmaceutica...
April 21, 2026
Based on market forecasts, the cell and gene therapy CDMO sector will expand from USD 6.41 billion in 2024 to USD 75.32 billion by 2034, experiencing a CAGR of 27.94%. In 2024, North America led the cell and gene therapy CDMO market with a 41% share,...
+1 9197 992 333
+91 93077 85324
